PlainPharmaWatch

CMS Open Payments · Program Year 2024

Paragon 28, Inc.

Paragon 28, Inc. reported $3,709,768.97 across General Payments, Research, and Ownership to 7,401 physicians and teaching hospitals across 7,452 transactions.

See the rankings → How this is sourced
$3.7M
All-tracks total
7,452
Transactions
7,401
Recipients
−$1.3M
General Payments vs PY2023

Paragon 28, Inc. reported $3,709,768.97 across all CMS Open Payments tracks (General + Research + Ownership) to 7,401 physicians and teaching hospitals in Program Year 2024 - ranking #319 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $3,438,475.24, averaging $501.25 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer paragon-28-inc Paragon 28, Inc.

$3.7M · #319/1,925 · 0.0% industry · PY2024

  • TOT $3.7M
  • RANK #319
  • SHARE 0.0%
  • TXN 7,452
  • RCP 7,401
  • CAT 5
  • GEN $3.4M
  • ΔGEN −$1.3M
  • TOP1 12.7%
  • PY 2024

Volume peers

Nearest volume peer: Adcura, Inc. ($3.7M)

Haemonetics Corporation$3.7MAxonics, Inc.$3.7MParagon 28, Inc. (this)$3.7MAdcura, Inc.$3.7MGramercy Extremity Orthopedi…$3.7M
All-tracks payment totals near Paragon 28, Inc. (CMS Open Payments PY2024)

Paragon 28, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Paragon 28, Inc.'s CMS-reported General Payments decreased by $1.3M (−26.9%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: PARAGON 28, INC.PY2023: PARAGON 28, INC.PY2024: Paragon 28, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$4.7MPY2024$3.4M
PY2023
$4,706,818.08
PY2024
$3,438,475.24

What the Data Shows for Paragon 28, Inc.

$3,709,768.97: that is what Paragon 28, Inc. reported in payments to 7,401 physicians and teaching hospitals during Program Year 2024, spread across 7,452 transactions ($497.82 per transaction, $501.25 per recipient). The company sits at rank #319 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Consulting Fee" leads the 5-category general-payment breakdown below at $1.4M (40.8% of General Payments, 435 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Across 5 types of general payments, Paragon 28, Inc.'s largest category was "Consulting Fee" at $1.4M - 40.8% of General Payments.

Paragon 28, Inc. reports 5 general-payment categories - the top three are Consulting Fee (40.8%), Grant (21.7%), and Royalty or License (18.1%). The remaining 2 categories make up 19.3% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.

How Paragon 28, Inc. divides its payments

General-payment categories, ordered by reported total

1. Consulting Fee$1.4M2. Grant$746.8K3. Royalty or License$624.1K4. Travel and Lodging$438.0K5. Food and Beverage$225.6K
Payment Type Amount Transactions
Consulting Fee $1.4M 435
Grant $746.8K 23
Royalty or License $624.1K 171
Travel and Lodging $438.0K 2,526
Food and Beverage $225.6K 4,246

Recipient Concentration in General Payments

The five largest recipient relationships account for $1,134,372.43 (33.0%) of $3,438,475.24 in this company's General Payments records across 1,919 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Paragon 28, Inc.

The five named recipients with the highest reported General Payments from this company

Duke University Hospital$435.0KMark Myerson$186.3KMark Dalton$182.5KThomas Sangiovanni$180.6KByron Hutchinson$150.0K
  1. 1

    Duke University Hospital

    $435,000.00 across 6 reported transactions

  2. 2

    Mark Myerson

    $186,257.79 across 64 reported transactions

  3. 3

    Mark Dalton

    $182,510.53 across 136 reported transactions

  4. 4

    Thomas Sangiovanni

    $180,622.53 across 65 reported transactions

  5. 5

    Byron Hutchinson

    $149,981.58 across 46 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Paragon 28, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Paragon 28, Inc..

Sonio

HHI 370

Regeneron Pharmaceuticals, Inc.

HHI 371

Visioneering Technologies, Inc.

HHI 369

Janssen Research & Development, LLC

HHI 372

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Paragon 28, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Paragon 28, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.